Public Meeting of the President's Council on Bioethics on November 8-9, 2007, 59093-59094 [07-5145]

Download as PDF Federal Register / Vol. 72, No. 201 / Thursday, October 18, 2007 / Notices includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than November 13, 2007. A. Federal Reserve Bank of Chicago (Burl Thornton, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690–1414: 1. IBT Bancorp, Inc., Mt. Pleasant, Michigan; to merge with Greenville Community Financial Corporation, and thereby indirectly acquire voting shares of Greenville Community Bank, both of Greenville, Michigan. Board of Governors of the Federal Reserve System, October 15, 2007. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc.E7–20562 Filed 10–17–07; 8:45 am] BILLING CODE 6210–01–S FEDERAL RESERVE SYSTEM Federal Open Market Committee; Domestic Policy Directive of September 18, 2007 mstockstill on PROD1PC66 with NOTICES In accordance with § 271.25 of its rules regarding availability of information (12 CFR part 271), there is set forth below the domestic policy directive issued by the Federal Open Market Committee at its meeting held on September 18, 2007.1 The Federal Open Market Committee seeks monetary and financial conditions that will foster price stability and promote sustainable growth in output. To further its long–run objectives, the Committee in the immediate future seeks conditions in reserve markets consistent with reducing the federal funds rate at an average of around 43⁄4 percent. 1 Copies of the Minutes of the Federal Open Market Committee meeting on September 18, 2007, which includes the domestic policy directive issued at the meeting, are available upon request to the Board of Governors of the Federal Reserve System, Washington, D.C. 20551. The minutes are published in the Federal Reserve Bulletin and in the Board’s annual report. VerDate Aug<31>2005 21:55 Oct 17, 2007 Jkt 214001 59093 By order of the Federal Open Market Committee, October 10, 2007. 6988 or by e-mail at marialhernandez@sra.com. Brian F. Madigan, Secretary, Federal Open Market Committee. [FR Doc. E7–20554 Field 10–17–07; 8:45 am] Linda Ott, Program Analyst, Federal Acquisition Institute [FR Doc. E7–20593 Filed 10–17–07; 8:45 am] BILLING CODE 6210–01–S BILLING CODE 6820–EP–S GENERAL SERVICES ADMINISTRATION DEPARTMENT OF HEALTH AND HUMAN SERVICES 2007 Federal Acquisition Institute Vendor meeting Office of the Chief Acquisition Officer, GSA ACTION: Notice of meeting. AGENCY: SUMMARY: The Federal Acquisition Institute (FAI) will hold a vendor meeting to provide information on the Federal Acquisition Certification in Program/Project Management (FAC-P/ PM) to include program details, and opportunities for vendors to support the training of federal program and project managers. The purpose of this certification program is to establish the competencies, training, and experience requirements for program and project managers in civilian agencies. The FACP/PM focuses on essential competencies needed for program and project managers; the program does not include functional or technical competencies, such as those for information technology, or agency-specific competencies. The certification requirements will be accepted by, at minimum, all civilian agencies as evidence that an employee meets the core competencies, training and experience requirements. The FAC-P/PM was announced by the Office of Federal Procurement Policy (OFPP) on April 25, 2007. At this vendor meeting, FAI will present its approach for partnering with vendors on this initiative. WHO SHOULD ATTEND? Training developers, vendors with Commercial-Off-The- Shelf (COTS) training products, vendors with capabilities related to the full Instructional System Design (ISD) methodologies, professional associations, educational institutions and acquisition training experts. The meeting will be held October 30, 2007 from 2:00 pm to 3:30 pm, GSA Auditorium located at 1800 F Street, NW, Washington, D.C. Register by email: marialhernandez@sra.com, or call (703) 284–6988. FOR FURTHER INFORMATION CONTACT: Ms. Maria Hernandez, by phone at 703–284– PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 Public Meeting of the President’s Council on Bioethics on November 8– 9, 2007 AGENCY: The President’s Council on Bioethics, HHS. ACTION: Notice. SUMMARY: The President’s Council on Bioethics (Edmund D. Pellegrino, MD, Chairman) will hold its thirty-first meeting, at which it will continue (1) its inquiry into the ‘‘crisis’’ of the healing professions with expert presentations and Council discussions; and (2) its inquiry into the moral foundations of health care. Subjects discussed at past Council meetings (although not on the agenda for the November 2007 meeting) include: Therapeutic and reproductive cloning, assisted reproduction, reproductive genetics, neuroscience, aging retardation, organ transplantation, newborn screening, human dignity, personalized medicine, and lifespanextension. Publications issued by the Council to date include: Human Cloning and Human Dignity: An Ethical Inquiry (July 2002); Beyond Therapy: Biotechnology and the Pursuit of Happiness (October 2003); Being Human: Readings from the President’s Council on Bioethics (December 2003); Monitoring Stem Cell Research (January 2004), Reproduction and ResponsibilityL: The Regulation of New Biotechnologies (March 2004), Alternative Sources of Human Pluripotent Stem Cells: A White Paper (May 2005), and Taking Care: Ethical Caregiving in Our Aging Society (September 2005). Reports on (a) the bioethical significance of the concept of human dignity, (b) controversies in the determination of death, and (c) organ procurement, transplantation, and allocation are forthcoming. DATES: The meeting will take place Thursday, November 8, 2007, from 9 a.m. to 5 p.m., ET; and Friday, November 9, 2007, from 9 a.m. to 11 a.m. ET. ADDRESSES: Hotel Washington, 515 15th Street (at Pennsylvania Avenue), NW., Washington, DC 20004. Phone 202–638– 5900. E:\FR\FM\18OCN1.SGM 18OCN1 59094 Federal Register / Vol. 72, No. 201 / Thursday, October 18, 2007 / Notices Agenda: The meeting agenda will be posted at https://www.bioethics.gov. Public Comments: The Council encourages public input, either in person or in writing. At this meeting, interested members of the public may address the Council, beginning at 10:45 a.m. on Friday, November 9. Comments are limited to no more than five minutes per speaker or organization. As a courtesy, please inform Ms. Diane M. Gianelli, Director of Communications, in advance of your intention to make a public statement, and give your name and affiliation. To submit a written statement, mail or e-mail it to Ms. Gianelli at one of the addresses given below. FOR FURTHER INFORMATION CONTACT: Ms. Diane M. Gianelli, Director of Communications, The President’s Council on Bioethics, 1425 New York Avenue, NW., Suite C100, Washington, DC 20005. Telephone: 202/296–4669. Email: info@bioethics.gov, Web site: https://www.bioethics.gov. Dated: October 10, 2007. F. Daniel Davis, Executive Director, The President’s Council on Bioethics. [FR Doc. 07–5145 Filed 10–17–07; 8:45 am] BILLING CODE 4154–06–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Health and Nutrition Examination Survey (NHANES) DNA Samples: Guidelines for Proposals To Use Samples and Cost Schedule Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice. mstockstill on PROD1PC66 with NOTICES AGENCY: SUMMARY: The National Health and Nutrition Examination Survey (NHANES) is a program of periodic surveys conducted by the National Center for Health Statistics (NCHS) of the Centers for Disease Control and Prevention (CDC). Examination surveys conducted since 1960 by NCHS have provided national estimates of the health and nutritional status of the U.S. civilian noninstitutionalized population. To add to the extensive amount of information collected for the purpose of describing the health of the population, DNA specimens were collected during two NHANES surveys. DNA is available in the form of crude lysates of cell lines derived from approximately 7,157 participants VerDate Aug<31>2005 21:55 Oct 17, 2007 Jkt 214001 enrolled in Phase II of NHANES III (1991–1994). In addition, DNA purified from whole blood is also available from approximately 7,900 participants enrolled in the 1999–2002 NHANES survey years. All specimens (NHANES III and NHANES 1999–2002 were sent to the Division of Laboratory Sciences (DLS) at the National Center for Environmental Health (NCEH) for processing. DNA samples from these specimens are being made available to the research community for genetic analyses. No funding is provided as part of this solicitation. NCHS will begin to accept proposals after the publication of this notice and will continue to accept proposals on an on-going basis. Proposals received within 60 days of the notice will complete review approximately 180 days after the notice is published. After this initial review of proposals, all proposal categories will be reviewed twice a year beginning January 1 and July 1 of each year. Unforeseen circumstances could result in a change to this schedule. Proposals will be reviewed by a technical panel and by an internal Secondary Review Committee of senior CDC scientists. The Secondary Review Committee will perform a programmatic review based on the results of the technical review panel and consider the scientific and technical results from the first level of review, important programmatic considerations such as program priorities, program relevance, and other criteria germane to this announcement and to CDC. Projects approved by both reviews will be submitted to the NCHS Ethics Review Board for final approval. Approved projects that do not obtain funding on their own will be canceled. A more complete description of this program follows. DATES: • Submission of Proposals: December 17, 2007, and thereafter on January 1 and July 1. • Scientific Review: 30 days after proposal submission date. • Secondary Review: Approximately 30 days after Scientific review is complete. • Ethics Review Board: Approximately 30 days after Secondary review is complete. • Notification of approval: Approximately 30 days after ERB approval. • Anticipated distribution of samples: Approximately 60 days after all approvals are obtained. Note: Timeframe may vary depending on the nature of the proposal and the results of each level of review. Unforeseen circumstances could result in a change to this schedule. PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 To send comments and for information, contact: Christopher Sanders, Division of Health and Nutrition Examination Surveys, National Center for Health Statistics, Centers for Disease Control and Prevention, 3311 Toledo Road, Room 4203, Hyattsville, MD 20782, Phone: 301–458–4840, FAX: 301–458–4028, Email: NHANESgenetics@cdc.gov. ADDRESSES: Authority: Sections 301 and 306 of the Public Health Service Act (42 U.S.C. 241 and 242k). The goals of NHANES are (1) to estimate the number and percentage of people in the U.S. population and designated subgroups with selected diseases and risk factors for those diseases; (2) to monitor trends in the prevalence, awareness, treatment and control of selected diseases; (3) to monitor trends in risk behaviors and environmental exposures; (4) to analyze risk factors for selected diseases; (5) to study the relation among diet, nutrition and health; (6) to explore emerging public health issues and new technologies; (7) to establish and maintain a national probability sample of baseline information on health and nutritional status. The availability of the NHANES III DNA samples has been previously announced (Thursday, August 8, 2002 [67 FR 51585] and Friday, January 13, 2006 [71 FR 22248]). NHANES III DNA samples are in the form of crude cell lysates available from the cell lines derived from samples obtained from Phase II (1991–1994) participants. DNA concentrations are unknown and vary between samples (see NHANES III DNA Samples section for a description). Beginning in 1999, NHANES became a continuous, annual survey rather than a periodic survey. For a variety of reasons, including disclosure and reliability issues, the survey data are released on public use data files every two years. In addition to the analysis of data from any two year cycle, it is possible to combine two cycles to increase sample size and analytic options. Blood samples for DNA purification were collected from participants age 20 or more years in survey years 1999–2002. Purified DNA samples are available from these survey years in a single set. DNA samples can be obtained and analyzed with survey data from the NHANES 1999–2000 or 2001–2002 or all four years combined (NHANES 1999–2002). The data release cycle for the NHANES during the period in which DNA specimens were collected is described as NHANES 1999–2000 and NHANES 2001–2002. SUPPLEMENTARY INFORMATION: E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 72, Number 201 (Thursday, October 18, 2007)]
[Notices]
[Pages 59093-59094]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-5145]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Public Meeting of the President's Council on Bioethics on 
November 8-9, 2007

AGENCY: The President's Council on Bioethics, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The President's Council on Bioethics (Edmund D. Pellegrino, 
MD, Chairman) will hold its thirty-first meeting, at which it will 
continue (1) its inquiry into the ``crisis'' of the healing professions 
with expert presentations and Council discussions; and (2) its inquiry 
into the moral foundations of health care. Subjects discussed at past 
Council meetings (although not on the agenda for the November 2007 
meeting) include: Therapeutic and reproductive cloning, assisted 
reproduction, reproductive genetics, neuroscience, aging retardation, 
organ transplantation, newborn screening, human dignity, personalized 
medicine, and lifespan-extension. Publications issued by the Council to 
date include: Human Cloning and Human Dignity: An Ethical Inquiry (July 
2002); Beyond Therapy: Biotechnology and the Pursuit of Happiness 
(October 2003); Being Human: Readings from the President's Council on 
Bioethics (December 2003); Monitoring Stem Cell Research (January 
2004), Reproduction and ResponsibilityL: The Regulation of New 
Biotechnologies (March 2004), Alternative Sources of Human Pluripotent 
Stem Cells: A White Paper (May 2005), and Taking Care: Ethical 
Caregiving in Our Aging Society (September 2005). Reports on (a) the 
bioethical significance of the concept of human dignity, (b) 
controversies in the determination of death, and (c) organ procurement, 
transplantation, and allocation are forthcoming.

DATES: The meeting will take place Thursday, November 8, 2007, from 9 
a.m. to 5 p.m., ET; and Friday, November 9, 2007, from 9 a.m. to 11 
a.m. ET.

ADDRESSES: Hotel Washington, 515 15th Street (at Pennsylvania Avenue), 
NW., Washington, DC 20004. Phone 202-638-5900.

[[Page 59094]]

    Agenda: The meeting agenda will be posted at https://
www.bioethics.gov.
    Public Comments: The Council encourages public input, either in 
person or in writing. At this meeting, interested members of the public 
may address the Council, beginning at 10:45 a.m. on Friday, November 9. 
Comments are limited to no more than five minutes per speaker or 
organization. As a courtesy, please inform Ms. Diane M. Gianelli, 
Director of Communications, in advance of your intention to make a 
public statement, and give your name and affiliation. To submit a 
written statement, mail or e-mail it to Ms. Gianelli at one of the 
addresses given below.

FOR FURTHER INFORMATION CONTACT: Ms. Diane M. Gianelli, Director of 
Communications, The President's Council on Bioethics, 1425 New York 
Avenue, NW., Suite C100, Washington, DC 20005. Telephone: 202/296-4669. 
E-mail: info@bioethics.gov, Web site: https://www.bioethics.gov.

    Dated: October 10, 2007.
F. Daniel Davis,
Executive Director, The President's Council on Bioethics.
[FR Doc. 07-5145 Filed 10-17-07; 8:45 am]
BILLING CODE 4154-06-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.